Skip to main content
Thorax logoLink to Thorax
. 1984 Jan;39(1):65–66. doi: 10.1136/thx.39.1.65

Serum interferon levels and natural killer cell activity in patients with asbestosis.

S Kagamimori, M Watanabe, M Kubota, A Okada, K Yokoyama, K Nobutomo
PMCID: PMC459723  PMID: 6198742

Abstract

Natural killer cell activity and serum interferon levels were measured in 30 patients with asbestosis. The chest radiographs showed type 1 changes (ILO pneumoconiosis classification) in nine, type 2 changes in 19, and type 3 changes in two. Thirty control subjects matched for age, sex, and smoking habit were also studied. Patients with asbestosis had significantly higher serum interferon levels than the controls. There was no significant difference in natural killer cell activity between patients with asbestosis and normal controls.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gilson J. C. Asbestos cancer: past and future hazards. Proc R Soc Med. 1973 Apr;66(4):395–403. doi: 10.1177/003591577306600445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hahon N., Eckert H. L. Depression of viral interferon induction in cell monolayers by asbestos fibers. Environ Res. 1976 Feb;11(1):52–65. doi: 10.1016/0013-9351(76)90110-9. [DOI] [PubMed] [Google Scholar]
  3. Ho M., White L. T., Haverkos H. W., Breinig M. C., Pazin G. J., Armstrong J. A. Depression of natural killer cell activity by interferon. J Infect Dis. 1981 Dec;144(6):605–605. doi: 10.1093/infdis/144.6.605. [DOI] [PubMed] [Google Scholar]
  4. Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979 Jul 5;301(1):5–8. doi: 10.1056/NEJM197907053010102. [DOI] [PubMed] [Google Scholar]
  5. Itoh K., Saitoh F., Kumagai K., Kosaka S. Depressed natural killer activity in rheumatoid arthritis and its in vitro augmentation with interferon and N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), an anti-arthritis agent. Ryumachi. 1981;21 (Suppl):69–74. [PubMed] [Google Scholar]
  6. Kiessling R., Haller O. Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol. 1978;8:171–201. doi: 10.1007/978-1-4684-0922-2_6. [DOI] [PubMed] [Google Scholar]
  7. Oshimi K., Sumiya M., Gonda N., Kano S., Takaku F. Natural killer cell activity in systemic lupus erythematosus. Lancet. 1979 Nov 10;2(8150):1023–1023. doi: 10.1016/s0140-6736(79)92603-5. [DOI] [PubMed] [Google Scholar]
  8. Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
  9. Targan S., Dorey F. Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC). Ann N Y Acad Sci. 1980;350:121–129. doi: 10.1111/j.1749-6632.1980.tb20613.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES